Who owns Immunome, Inc.?
Institutional ownership of IMNM from SEC Form 13F filings across 136 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
136
13F holders
$1.46B
value, 2026 filers
74.1%
of shares outstanding (70.8M sh)
22
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of IMNM's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 17.0M | $360.0M | 0.0% | 17.8% | +0.1% |
| 2 | BlackRock, Inc. | 8.8M | $186.6M | 0.0% | 9.2% | +7.8% |
| 3 | WELLINGTON MANAGEMENT GROUP LLP | 5.2M | $110.4M | 0.0% | 5.5% | +10.1% |
| 4 | PRIMECAP MANAGEMENT CO/CA/ | 4.6M | $97.1M | 0.1% | 4.8% | -4.3% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 4.6M | $96.4M | 0.0% | 4.8% | -48.6% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.8M | $58.4M | 0.0% | 2.9% | +7.6% |
| 7 | MORGAN STANLEY | 2.4M | $51.0M | 0.0% | 2.5% | -15.3% |
| 8 | JPMORGAN CHASE & CO | 1.8M | $39.0M | 0.0% | 1.9% | -33.5% |
| 9 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.8M | $37,576 | 0.0% | 1.9% | -38.0% |
| 10 | READYSTATE ASSET MANAGEMENT LP | 1.6M | $34.0M | 1.2% | 1.7% | +23.3% |
| 11 | GOLDMAN SACHS GROUP INC | 1.5M | $32.0M | 0.0% | 1.6% | +37.3% |
| 12 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.3M | $28.6M | 0.0% | 1.4% | +34.0% |
| 13 | PRINCIPAL FINANCIAL GROUP INC | 1.3M | $28.6M | 0.0% | 1.4% | -2.1% |
| 14 | BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1.3M | $26.5M | 0.0% | 1.3% | +13.9% |
| 15 | Woodline Partners LP | 1.0M | $21.2M | 0.1% | 1% | -68.2% |
| 16 | NORTHERN TRUST CORP | 968,346 | $20.5M | 0.0% | 1% | +7.7% |
| 17 | Sixth Street Partners Management Company, L.P.NEW | 886,193 | $18.8M | 3.2% | 0.9% | new |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 886,193 | $18.8M | 0.0% | 0.9% | +4.0% |
| 19 | MetLife Investment Management, LLC | 859,076 | $18.2M | 0.1% | 0.9% | +1438.0% |
| 20 | VANGUARD FIDUCIARY TRUST CO | 756,297 | $16.0M | 0.0% | 0.8% | +5.6% |
| 21 | TD Asset Management Inc | 719,272 | $15.2M | 0.0% | 0.8% | +3.5% |
| 22 | Candriam S.C.A. | 680,132 | $14.4M | 0.1% | 0.7% | +26.0% |
| 23 | BANK OF AMERICA CORP /DE/ | 647,888 | $13.7M | 0.0% | 0.7% | -17.1% |
| 24 | MARSHALL WACE, LLP | 500,537 | $10.6M | 0.0% | 0.5% | -66.2% |
| 25 | Qube Research & Technologies Ltd | 439,186 | $9.3M | 0.0% | 0.5% | +133.3% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.